Skip to main content

Advertisement

Table 2 Patient characteristics validation group (N = 31)

From: Quantification of excretory renal function and urinary protein excretion by determination of body cell mass using bioimpedance analysis

  Mean ± SD Median (P25, P75) Minimum, Maximum
Age; y 57 ± 16 57 (47, 69) 21, 82
Plasma creatinine; μmol/L 174.6 ± 100.1 157 (87.5, 222.5) 68.0, 373.0
Creatinine, 24hU; mmol 11.30 ± 3.42 11.3 (8.73, 14.50) 6.54, 17.80
CrCl; mL/min/1.73 m2 58.4 ± 37.5 44.0 (26.7, 89.8) 14.2, 137.0
eCrCl (Cockcroft-Gault); mL/min/1.73 m2 54.6 ± 35.2 37.9 (36.4, 86.6) 11.1, 201.1
eGFR (4vMDRD); mL/min/1.73 m2 49.0 ± 32.3 34.0 (20.5, 78.5) 10.0, 115.0
eGFR (CKD-EPI); mL/min/1.73 m2 52.0 ± 36.2 37.0 (20.5, 84.0) 10.0, 128.0
Body weight; kg 80.5 ± 13.7 76.4 (71.7, 85.3) 51.4, 113.4
Body height; cm 167 ± 10 167 (160, 173) 147, 187
BMI kg/m2 28.70 ± 5.3 27.5 (25.2, 29.8) 20.1, 45.4
Body Surface Area; m2 1.81 ± 0.61 1.88 (1.73, 2.01) 1.51, 2.25
BIA Free Fat Mass; kg 54.0 ± 11.3 50.0 (44.3, 57.0) 36.9, 91.2
BIA Body Cell Mass; kg 25.2 ± 6.3 24.4 (19.1, 30.1) 14.2, 37.7
Abdominal circumference; cm 104 ± 11 103 (94, 108) 91, 115
Hip circumference; cm 99 ± 13 100 (95, 104) 68, 112
Waist/hip ratio 0.99 ± 0.12 0.98 (0.95, 1.02) 0.74, 1.13